Pyelonephritis Acute clinical trials

Explore recruiting pyelonephritis acute clinical trials.

Recruiting pyelonephritis acute studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pyelonephritis Acute trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Open-label, Multicentre, Single-Arm Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of VaboremⓇ (Meropenem-Vaborbactam) in Paediatric Population with suspected or confirmed Gram negative infections, including but not restricted to Complicated Urinary Tract Infections.

Czechia, Italy, Spain, Poland, France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Single Group Treatment, Phase 2 study to investigate Pharmacokinetics, Safety and Tolerability of Cefepime-Enmetazobactam administered by intra-venous infusion over 2 hours in Male or Female Participants from birth to less than 18 years of age hospitalized with complicated urinary tract infections (cUTI) including Acute Pyelonephritis (AP).

Czechia, Hungary, Spain, Poland, Slovakia, France

Therapeutic exploratory (Phase II) EU CTIS Study details

Pyelonephritis Acute trials by city

Pyelonephritis Acute clinical trials

Recruiting pyelonephritis acute studies right now

A Trial of HRS-8427 in the Treatment of Adults With Complicated Urinary Tract Infection, Including Acute Pyelonephritis

The Validity of the Quick Renal MRI in Pediatric Kidney Disease

3-day IV Antibiotic Treatment Versus 3-day IV Followed by 7-day Oral Antibiotic Treatment for AP in Children

Efficacy of 7 Days Versus 14 Days of Antibiotic Therapy for Acute Pyelonephritis in Kidney Transplant Recipients, a Multicentre Randomized Non-inferiority Trial.

Also recruiting in Europe

An Open-label, Multicentre, Single-Arm Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of VaboremⓇ (Meropenem-Vaborbactam) in Paediatric Population with suspected or confirmed Gram negative infections, including but not restricted to Complicated Urinary Tract Infections.

Pyelonephritis Acute trials by city

Other conditions